Elucidating the energy transfer process in mononuclear and binuclear lanthanide complexes of the anti-inflammatory drug ibuprofen: From synthesis to high luminescence emission.

This work presents the synthesis, solid state characterization and complete photoluminescence study of three new important classes of lanthanide complexes containing the non-steroidal anti-inflammatory drug (NSAID) Ibuprofen. The analytical and spectroscopic data reveals the formation of nine complexes with the general formula [Ln(Ibf) 3 (H 2 O) 2 ] , [Ln 2 (Ibf) 6 (bpy) 2 ] and [Ln 2 (Ibf) 6 (phen) 2 ] (Ln=Eu III , Gd III and Tb III , Ibf=Ibuprofen ligand, bpy=2,2′- bipyridine and phen=1,10-phenanthroline). The molecular structures of the Eu III complexes were calculated using the RM1 model, and your optimized ground state geometries were used to calculated all details involved in the energy transfer process and compared with experimental data. The phosphorescence measurements of the Gd III complexes, allowed the identification of the lowest ligand triplet state, proving that the photoluminescence in the Eu III and Tb III Ibuprofen complexes is proposed to be a ligand sensitized luminescence process. The presence of N,N-donors (bpy or phen) in the structure of the Eu III Ibuprofen complexes results in an 3 to 4-fold increase in the quantum efficiency when compared with the Eu III complex without N,N-donors ligands. The high emission quantum efficiency ( η =69–80%) for Eu III complexes showed that they can be potential candidates as emitters in biologic assays. [ABSTRACT FROM AUTHOR]